Quantcast

Latest Progressive Supranuclear Palsy Stories

2011-06-24 07:51:00

(Ivanhoe Newswire)--The second most common cause of degenerative Parkinsonism is a devastating disease that currently has no available treatment. The disease is called progressive supranuclear palsy, or PSP, and is a form of frontotemporal dementia that affects around three to six people per 100,000. According to a new study conducted by researchers from the Perelman School of Medicine at the University of Pennsylvania, there are new genetic clues on the risk factors and biological causes of...

2011-06-20 13:15:12

An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications. Their report is being published online June 19 in Nature Genetics. The findings provide a "testable translational hypothesis" as to the development and...

2011-06-20 12:44:36

Initial step towards early identification and treatment of progressive supranuclear palsy There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. In the largest genetics study of the disease, three new genes associated with risk for PSP were identified...

2011-06-19 12:00:00

TIMONIUM, Md., June 19, 2011 /PRNewswire/ -- An international team of researchers led by Gerard D. Schellenberg, PhD, a member of the CurePSP Genetics Consortium and professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has identified three new genes that can increase the risk of people developing Progressive Supranuclear Palsy (PSP). To view the multimedia assets associated with this release, please click:...

2011-05-08 23:01:00

MADISON, Wis., May 9, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System (CNS) disorders, announces that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy (PSP). Orphan status entitles Mithridion to seven years of market exclusivity upon approval of MCD-386 for treating PSP, and...

2010-09-09 14:36:00

MADRID, Sept. 9 /PRNewswire/ -- Noscira, a Grupo Zeltia (ZEL.MC) subsidiary specialized in research and development of drugs to treat neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive Supranuclear Palsy (PSP), a fast-advancing fatal degenerative brain disorder. A Phase II trial with Tideglusib (ZentylorTM) in PSP commenced in December 2009 and is...

2009-09-21 09:00:00

Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Dementias study identifies funding gaps, opportunities for accelerating drug discovery and development NEW YORK, Sept. 21 /PRNewswire-USNewswire/ -- Neurodegenerative disorders called frontotemporal dementias (FTD) are the second-leading cause of early-onset dementia in persons under age 65 and can emerge sometimes as early as age 20. While research over the past 10 years has contributed much to the understanding...

2006-02-01 13:16:08

By Michelle Rizzo NEW YORK (Reuters Health) - Brain lesions known as neurofibrillary tangles, such as those seen in Alzheimer's disease, are also associated with impaired gait in older subjects with or without dementia, according to a postmortem study. "The more tangles an older person had in the substantia nigra" - an area of the brain associated with Parkinson's disease -- "the more problems there were with gait," lead author Dr. Julie A. Schneider told Reuters Health. Results...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related